Vaccination resulted in the expansion of myeloma-specific T cells in a majority of patients as manifested by the percent of CD4 and/or CD8 T cells expressing IFNγ following ex vivo exposure to autologous tumor lysate. The gene discussed is CD4; the disease is neoplasm.